Cellid Submits Application for COVID-19 Vaccine Phase 2b Clinical Trial to MFDS
[Asia Economy Reporter Ji Yeon-jin] Cellid announced on the 12th that it has submitted a clinical trial plan for Phase 2b/3 of the COVID-19 preventive vaccine (AdCLD-CoV19-1) to the Ministry of Food and Drug Safety.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- The "90% Mystery" Dominating Teenagers: "Just the Tip of the Iceberg"—Experts Shocked by Record Numbers [ChwiYakGuk] ⑨
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "Bought for a Special Price, but Cheaper Today"... Online Malls Caught Inflating Discount Rates by Raising Regular Prices
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Cheaper Than Mychew, but Nowhere to Be Found... Fears of a 'Pediatric Medical Crisis' as Drug Makers Halt Production [Why&Next]](https://cwcontent.asiae.co.kr/asiaresize/307/2026051910065268365_1779152813.jpg)
